Company intelligence / Profile preview

Corza Medical

Westwood, Massachusetts, USAcorza.com ↗

Ownership: Private
Employees: ~3000
Development stage: Commercial

Overview

Corza Medical provides commercialized surgical technologies across wound closure, ophthalmology, biosurgery, and biomedical textiles. Its flagship products include Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Katena reusable and Blink single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint microsurgical knives, and the TachoSil fibrin sealant patch. The company operates globally with over $500 million revenue annually. No clinical trial results are reported as the focus is on medical devices already on the market.

Therapeutic areas: OtherCardiovascularOphthalmologyHematology
Modalities: DeviceBiologicBiomedical textileProteinSuture technology
Industry: Surgical Medical Devices

Drug pipeline

1 asset

TachoSil

Commercial

Indications: Surgical hemostasis

Beyond the preview

Go deeper on Corza Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corza Medical.

Explore the full profile